The Chicago Entrepreneur

Earnings Results: Novavax stock shedding a quarter of its value as vaccine maker’s business in ‘substantial doubt’

Novavax shares shares sank late Tuesday after reporting more than double the loss that analysts expected and disclosing that it make it another year.

Previous post : FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
Next post Pro expects BTC and Nasdaq 100 to be more correlated moving forward